Flare Therapeutics divulges new PPARγ inverse agonists for treatment of bladder cancer
Sep. 29, 2023
Flare Therapeutics Inc. has patented peroxisome proliferator-activated receptor γ (PPARγ, PPARG) inverse agonists reported to be useful for the treatment of bladder cancer.